In addition, MEOX2 promoter sequences were recently used as part of a test for cancer-specific DNA methylation cluster markers in colorectal cancer [31], and TWIST1 methylation was assessed at promoter sequences in lung AD patients [32]. Here, TWIST1 is linked to cancer.